Mobi Health News – MINDCURE begins North American release of digital therapeutic for psychedelic therapy

MINDCURE is releasing the minimum viable product (MVP) of digital therapeutic platform iSTRYM. Its functions include patient onboarding, gathering & providing data, and music therapy during psychedelic-assisted therapy sessions. The increase in mental health issues has led to the re-examination of psychedelic drugs for therapeutic uses, which companies such as TRIPP and MindMed are also pursuing in tandem with digital therapeutics.

Access the article here.